BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 2623438)

  • 21. The assessment of schizotypal features over two points in time.
    Squires-Wheeler E; Skodol AE; Erlenmeyer-Kimling L
    Schizophr Res; 1991 Dec; 6(1):75-85. PubMed ID: 1786236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of vulnerability among first-degree relatives of patients with schizophrenia.
    Solanki RK; Swami MK; Singh P; Gupta S
    East Asian Arch Psychiatry; 2012 Sep; 22(3):118-25. PubMed ID: 23019286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do schizotypal symptoms mediate the relationship between genetic risk for schizophrenia and impaired neuropsychological performance in co-twins of schizophrenic patients?
    Johnson JK; Tuulio-Henriksson A; Pirkola T; Huttunen MO; Lönnqvist J; Kaprio J; Cannon TD
    Biol Psychiatry; 2003 Dec; 54(11):1200-4. PubMed ID: 14643087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temperament and character dimensions of the relatives of schizophrenia patients and controls: the relationship between schizotypal features and personality.
    Bora E; Veznedaroglu B
    Eur Psychiatry; 2007 Jan; 22(1):27-31. PubMed ID: 17129710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [EASE: Examination of Anomalous Self-Experience].
    Parnas J; Møller P; Kircher T; Thalbitzer J; Jansson L; Handest P; Zahavi D; Cermolacce M; Bovet P
    Encephale; 2012 Dec; 38 Suppl 3():S121-45. PubMed ID: 23279986
    [No Abstract]   [Full Text] [Related]  

  • 26. Verbal learning and memory in relatives of schizophrenics: preliminary findings.
    Lyons MJ; Toomey R; Seidman LJ; Kremen WS; Faraone SV; Tsuang MT
    Biol Psychiatry; 1995 May; 37(10):750-3. PubMed ID: 7640330
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: an update.
    Lenzenweger MF
    Schizophr Bull; 1994; 20(1):121-35. PubMed ID: 8197410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Rust Inventory of Schizotypal Cognitions (RISC).
    Rust J
    Schizophr Bull; 1988; 14(2):317-22. PubMed ID: 3201182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and validity of the Cognitive Slippage Scale in two populations.
    Osman A; Valeri L; Osman JR; Jones K
    Psychol Rep; 1992 Feb; 70(1):131-6. PubMed ID: 1565710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties and concurrent validity of the schizotypal ambivalence scale.
    Kwapil TR; Mann MC; Raulin ML
    J Nerv Ment Dis; 2002 May; 190(5):290-5. PubMed ID: 12011608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability of measuring anomalous experience: the Bonn Scale for the Assessment of Basic Symptoms.
    Vollmer-Larsen A; Handest P; Parnas J
    Psychopathology; 2007; 40(5):345-8. PubMed ID: 17657133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia.
    Keefe RS; Silverman JM; Mohs RC; Siever LJ; Harvey PD; Friedman L; Roitman SE; DuPre RL; Smith CJ; Schmeidler J; Davis KL
    Arch Gen Psychiatry; 1997 Feb; 54(2):169-76. PubMed ID: 9040285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The factorial structure of schizotypy: Part I. Affinities with syndromes of schizophrenia.
    Gruzelier JH
    Schizophr Bull; 1996; 22(4):611-20. PubMed ID: 8938915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between schizotypal features and indicators of neurological and morphological abnormalities.
    Bollini AM; Compton MT; Esterberg ML; Rutland J; Chien VH; Walker EF
    Schizophr Res; 2007 May; 92(1-3):32-40. PubMed ID: 17363219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vulnerability to schizophrenia: neuropsychological performance and schizotypal personality traits].
    Laurent A; Halim V; Sechier P; Daumal M; Foussard N; Dumas P; Daléry J; d'Amato T
    Encephale; 2001; 27(2):173-9. PubMed ID: 11407270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creating school-age versions of semistructured interviews for the prodrome to schizophrenia: lessons from case reviews.
    Ross RG; Schaeffer J; Compagnon N; Heinlein S; Beresford C; Farley G
    Schizophr Bull; 2003; 29(4):729-35. PubMed ID: 14989410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia.
    Kendler KS; Thacker L; Walsh D
    Schizophr Bull; 1996; 22(3):511-20. PubMed ID: 8873301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reliability of DSM-III prodromal symptoms in first-episode psychotic patients.
    Jackson HJ; McGorry PD; McKenzie D
    Acta Psychiatr Scand; 1994 Nov; 90(5):375-8. PubMed ID: 7872043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological soft signs in schizophrenia.
    Rossi A; De Cataldo S; Di Michele V; Manna V; Ceccoli S; Stratta P; Casacchia M
    Br J Psychiatry; 1990 Nov; 157():735-9. PubMed ID: 2132562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New diagnostic criteria of deficits in schizophrenia by the Carpenter school: importance and validity].
    Ribeyre JM; Lesieur P; Varoquaux O; Dollfus S; Petit M
    Ann Med Psychol (Paris); 1993 Apr; 151(4):316-20; discussion 320-1. PubMed ID: 8285500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.